Inicio › Sarcoma del tejido blando › Ohio
Ensayos clínicos de Sarcoma del tejido blando en Ohio
21 estudios sobre Sarcoma del tejido blando buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
ReclutandoFase 1/2
Edades de 2 a 30 · Todos los sexos · Actualizado el 5 nov 2026 · NCT05734066A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Cleveland Clinic - Oncology Department, Cleveland
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06760819Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Cleveland Clinic, Cleveland
- Ohio State University, Columbus
ReclutandoFase 1/2
Edades de 18 a 90 · Todos los sexos · Actualizado el 28 oct 2026 · NCT06710756STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- University Hospitals Cleveland Medical Center, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT06975293Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
- Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06528769DESTINY-PANTUMOUR04
- Research Site, Canton
- Research Site, Maumee
ReclutandoEstudio observacional
Edades de 18 a 130 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07124000Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 1
Edades de 12 a 85 · Todos los sexos · Actualizado el 8 sept 2026 · NCT03715933Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Nationwide Children's Hospital, Columbus
ReclutandoFase 1/2
Edades de 12 a 40 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07725380A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
- The James Cancer Hospital and Solove Research Institute, Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT06263231Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT05210374NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 1/2
Hasta los 30 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06239272Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
- OSU James Hospital, Columbus
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jul 2026 · NCT07377747Integrated Cancer Repository for Cancer Research
- Aultman Alliance Community Hospital, Alliance
- Aultman Hospital, Canton
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- The Ohio State University Wexner Medical Center, Columbus
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 27 may 2026 · NCT03093116An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
- Ohio State University, Columbus
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 feb 2026 · NCT0267796168Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
- Ohio State University Comprehensive Cancer Center, Columbus
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 feb 2026 · NCT06500065A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 dic 2025 · NCT0694352164Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 1/2
Edades de 15 en adelante · Todos los sexos · Actualizado el 12 ago 2025 · NCT06298916A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
ReclutandoFase 2
18 Months – 40 Years · Todos los sexos · Actualizado el 12 ago 2025 · NCT05135975A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Cleveland Clinic, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 nov 2024 · NCT05824975REtroperitoneal SArcoma Registry: an International Prospective Initiative
- The Ohio State University, Columbus
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 feb 2019 · NCT03838718De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.